Tower Research Capital LLC (TRC) - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is and the CUSIP is 66987P300. A total of 22 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$1,597
-31.0%
15,210
+34.2%
0.00%
Q4 2023$2,313
-54.1%
11,336
+1.3%
0.00%
Q3 2023$5,034
-40.2%
11,187
-0.1%
0.00%
Q2 2023$8,41711,1930.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Blue Trust, Inc. 37$40.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders